Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Churchill Asset Management is a U.S. private capital and private credit investment manager focused on financing private equity-backed middle-market companies. The firm provides first lien, unitranche, second lien and mezzanine debt, as well as equity co-investments, secondary solutions and private equity fund commitments. Churchill operates as a Nuveen investment specialist and benefits from the broader resources of Nuveen and TIAA. It is not a biotechnology, pharmaceutical, or healthcare operating company; rather, it is a financial services business that may invest across multiple industries, including healthcare-related businesses.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Churchill Asset Management.